![NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation | Nature Communications NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-16936-9/MediaObjects/41467_2020_16936_Fig1_HTML.png)
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation | Nature Communications
![What is the Difference Between BRCA1 and BRCA2? | Roswell Park Comprehensive Cancer Center - Buffalo, NY What is the Difference Between BRCA1 and BRCA2? | Roswell Park Comprehensive Cancer Center - Buffalo, NY](http://www.roswellpark.org/sites/default/files/2020-06/adobestock_324998062-converted.png)
What is the Difference Between BRCA1 and BRCA2? | Roswell Park Comprehensive Cancer Center - Buffalo, NY
![Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance | EMBO Molecular Medicine Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/134b9da0-44c7-443f-9ff0-0480e770a18c/emmm201809982-abs-0001-m.jpg)
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance | EMBO Molecular Medicine
![Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer [PeerJ] Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7976/1/fig-1-full.png)
Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer [PeerJ]
![A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies - Shao - 2022 - Environmental and Molecular Mutagenesis - A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies - Shao - 2022 - Environmental and Molecular Mutagenesis -](https://onlinelibrary.wiley.com/cms/asset/ec3817ae-2c28-4332-805c-a4927711d33c/em22505-fig-0001-m.jpg)
A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies - Shao - 2022 - Environmental and Molecular Mutagenesis -
![Mechanism of Tumor Suppressor Genes. The most common genetic markers... | Download Scientific Diagram Mechanism of Tumor Suppressor Genes. The most common genetic markers... | Download Scientific Diagram](https://www.researchgate.net/publication/334284465/figure/fig2/AS:778017018228739@1562505120449/Mechanism-of-Tumor-Suppressor-Genes-The-most-common-genetic-markers-include-z-BRCA.jpg)
Mechanism of Tumor Suppressor Genes. The most common genetic markers... | Download Scientific Diagram
![Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers | JCO Precision Oncology Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2023/po.2023.7/po.23.00036/20230801/images/large/po.23.00036t2.jpeg)
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers | JCO Precision Oncology
![Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | Nature Cancer Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | Nature Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-020-00139-8/MediaObjects/43018_2020_139_Fig1_HTML.png)
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | Nature Cancer
![BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma | DNA and Cell Biology BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma | DNA and Cell Biology](https://www.liebertpub.com/cms/10.1089/dna.2020.5644/asset/images/medium/dna.2020.5644_figure1.jpg)
BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma | DNA and Cell Biology
![Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3fef50f667e7a94d557b63ba6d277af23a5057dc/3-Table1-1.png)